Bausch & Lomb holds up US launch of intraocular lens after reports Of calcification problems
This article was originally published in Clinica
Executive Summary
Bausch & Lomb has delayed the US launch of its HydroView intraocular lens, after reports of a number of adverse incidents where the lens calcified and became opaque. In some cases, surgeons had to remove the lens due to the serious visual impairment it caused the patient.